Concepedia

Publication | Closed Access

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab

DOI

122

Citations

23

References

2018

Year

Emilio Portaccio, Pietro Annovazzi, Angelo Ghezzi, Mauro Zaffaroni, Lucia Moiola, Vittorio Martinelli, Roberta Lanzillo, Vincenzo Brescia Morra, Francesca Rinaldi, Paolo Gallo,
Neurology

Abstract

This study provides Class III evidence that in women with MS, natalizumab exposure increases the risk of spontaneous abortion as compared to IFN-β-exposed or untreated patients (OR 3.9, 95% CI 1.9-8.5).

References

YearCitations

Page 1